SCHEMBL3826323

SCHEMBL3826323

COc1cc2cnc(-c3ccccc3C)cc2cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.50
RAB9A P51151 3/20 0.50
CYP1A2 P05177 5/20 0.46
CYP2C19 P33261 5/20 0.46
CYP2D6 P10635 4/20 0.46
CYP3A4 P08684 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 2/20 0.46
TSHR P16473 2/20 0.46
TP53 P04637 1/20 0.46
HIF1A Q16665 1/20 0.46
PDGFRB P09619 2/20 0.46
PDGFRA P16234 2/20 0.46
ALDH1A1 P00352 4/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28784063 0.87 PDGFRB (0.55) NPC1RAB9ACYP1A2CYP2C19CYP2D6
SCHEMBL14102704 0.83 NPC1 (0.72) NPC1RAB9ACYP1A2CYP2C19CYP2D6
SCHEMBL3831280 0.83 ALDH1A1 (0.44) NPC1RAB9APDGFRBPDGFRAALDH1A1
SCHEMBL807820 0.80 NPC1 (0.62) NPC1RAB9ACYP1A2CYP2C19CYP2D6
SCHEMBL3318438 0.79 NPC1 (0.69) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL3826324 0.78 L3MBTL1 (0.50) NPC1RAB9ACYP1A2CYP2C19CYP2D6
SCHEMBL3831411 0.78 CASP3 (0.50) NPC1RAB9ACYP1A2CYP2C19CYP2D6
Hydrochloric Acid SCHEMBL3318446 0.78 NPC1 (0.67) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL8887931 0.76 MEN1 (0.50) NPC1RAB9ACYP1A2CYP2C19CYP2D6
SCHEMBL3825502 0.76 CASP3 (0.49) NPC1RAB9ACYP1A2CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099765-A2 5, 6, OR 7-SUBSTITUTED-3-(HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS Rexahn Pharmaceuticals, Inc. (US) 2009-09-16 EP disclosed
WO-2008063548-A2 5, 6, OR 7-SUBSTITUTED-S- (HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS REXAHN PHARMACEUTICALS, INC. (US) 2008-05-29 WO disclosed